INDO US BIO-TECH | HIMALYA INT. | INDO US BIO-TECH/ HIMALYA INT. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | -5.2 | - | View Chart |
P/BV | x | 8.6 | 1.1 | 781.1% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH HIMALYA INT. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
HIMALYA INT. Mar-23 |
INDO US BIO-TECH/ HIMALYA INT. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 29 | 432.7% | |
Low | Rs | 25 | 16 | 152.4% | |
Sales per share (Unadj.) | Rs | 61.6 | 11.8 | 521.1% | |
Earnings per share (Unadj.) | Rs | 7.2 | -4.2 | -172.7% | |
Cash flow per share (Unadj.) | Rs | 8.0 | -3.0 | -267.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 23.0 | 236.3% | |
Shares outstanding (eoy) | m | 10.03 | 57.87 | 17.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 1.9 | 63.6% | |
Avg P/E ratio | x | 10.4 | -5.4 | -191.8% | |
P/CF ratio (eoy) | x | 9.4 | -7.6 | -123.7% | |
Price / Book Value ratio | x | 1.4 | 1.0 | 140.2% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 1,314 | 57.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 42 | 30.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 684 | 90.3% | |
Other income | Rs m | 0 | 291 | 0.1% | |
Total revenues | Rs m | 618 | 975 | 63.3% | |
Gross profit | Rs m | 94 | -467 | -20.1% | |
Depreciation | Rs m | 8 | 68 | 12.1% | |
Interest | Rs m | 12 | 3 | 363.9% | |
Profit before tax | Rs m | 74 | -247 | -29.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | -5 | -28.1% | |
Profit after tax | Rs m | 72 | -242 | -29.9% | |
Gross profit margin | % | 15.2 | -68.3 | -22.3% | |
Effective tax rate | % | 2.0 | 2.1 | 94.2% | |
Net profit margin | % | 11.7 | -35.4 | -33.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 405 | 147.9% | |
Current liabilities | Rs m | 123 | 803 | 15.3% | |
Net working cap to sales | % | 77.1 | -58.1 | -132.7% | |
Current ratio | x | 4.9 | 0.5 | 965.3% | |
Inventory Days | Days | 1 | 308 | 0.5% | |
Debtors Days | Days | 146,261,410 | 1,637 | 8,935,735.8% | |
Net fixed assets | Rs m | 90 | 1,825 | 4.9% | |
Share capital | Rs m | 100 | 579 | 17.3% | |
"Free" reserves | Rs m | 445 | 752 | 59.2% | |
Net worth | Rs m | 545 | 1,331 | 41.0% | |
Long term debt | Rs m | 17 | 0 | - | |
Total assets | Rs m | 689 | 2,230 | 30.9% | |
Interest coverage | x | 7.2 | -73.9 | -9.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.3 | 292.4% | |
Return on assets | % | 12.3 | -10.7 | -114.6% | |
Return on equity | % | 13.3 | -18.2 | -73.1% | |
Return on capital | % | 15.3 | -18.3 | -83.4% | |
Exports to sales | % | 0 | 49.4 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 338 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 338 | 0.0% | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 338 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 65 | 8.1% | |
From Investments | Rs m | -67 | -28 | 238.4% | |
From Financial Activity | Rs m | 63 | -39 | -160.8% | |
Net Cashflow | Rs m | 1 | -2 | -74.2% |
Indian Promoters | % | 70.2 | 42.1 | 166.6% | |
Foreign collaborators | % | 0.0 | 8.4 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 49.5 | 60.3% | |
Shareholders | 1,166 | 30,854 | 3.8% | ||
Pledged promoter(s) holding | % | 0.0 | 26.7 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | HIMALYA INT. |
---|---|---|
1-Day | 8.77% | -4.61% |
1-Month | 26.17% | 10.46% |
1-Year | 113.64% | 6.53% |
3-Year CAGR | 152.58% | 39.67% |
5-Year CAGR | 42.16% | 25.79% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the HIMALYA INT. share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of HIMALYA INT. the stake stands at 50.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of HIMALYA INT..
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
HIMALYA INT. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of HIMALYA INT..
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.